New York State Common Retirement Fund
ATNM icon

New York State Common Retirement Fund’s Actinium Pharmaceuticals ATNM Stock Holding History

New York State Common Retirement Fund’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,737
Closed -$10.8K – 3209
2025
Q1 		$10.8K Hold
6,737
– – ﹤0.01% 3071
2024
Q4 		$8.49K Hold
6,737
– – ﹤0.01% 3119
2024
Q3 		$12.7K Hold
6,737
– – ﹤0.01% 3090
2024
Q2 		$49.9K Sell
6,737
-5,846
-46% -$48.1K ﹤0.01% 3088
2024
Q1 		$98.5K Sell
12,583
-50
-0.4% -$321 ﹤0.01% 2743
2023
Q4 		$64.2K Sell
12,633
-58
-0.5% -$299 ﹤0.01% 2919
2023
Q3 		$75.1K Buy
12,691
+291
+2% +$1.94K ﹤0.01% 2863
2023
Q2 		$92K Buy
+12,400
New +$106K ﹤0.01% 2930
2015
Q3 		– Sell
-293
Closed -$23K – 3163
2015
Q2 		$23K Buy
+293
New +$25K ﹤0.01% 3271

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

New York State Common Retirement Fund's ATNM Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Actinium Pharmaceuticals (ATNM) in Q2 2025, closing a stake of 6,737 shares — an estimated $10.8K sold.

New York State Common Retirement Fund first reported a position in ATNM in Q2 2015 and held it in 9 quarters. The position peaked at $98.5K in Q1 2024. 63 funds tracked by Wall St. Rank hold ATNM as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Actinium Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 6,737 Actinium Pharmaceuticals shares in Q2 2025, an estimated $10.8K.
  • New York State Common Retirement Fund first reported a position in Actinium Pharmaceuticals in Q2 2015 and held it in 9 quarters.
  • New York State Common Retirement Fund's Actinium Pharmaceuticals position peaked at $98.5K in Q1 2024.
  • 63 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.